[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Retinal Drugs and Biologics Market Report 2018

February 2018 | 113 pages | ID: U72E65C3DB2EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Retinal Drugs and Biologics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Retinal Drugs and Biologics in these regions, from 2013 to 2025 (forecast).
United States Retinal Drugs and Biologics market competition by top manufacturers/players, with Retinal Drugs and Biologics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Alimera Sciences
  • Janssen Biotech
  • F. Hoffmann-La Roche Ltd
  • Genzyme Corporation
  • Ocular Therapeutix
  • UCBCares
  • Allergan
  • AbbVie Inc
  • Swedish Orphan Biovitrum
  • Bristol-Myers Squibb Company
  • Genentech USA
  • Bausch & Lomb Incorporated
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Surgery
  • Medicines
  • Retinal Laser
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Ophthalmology Clinics
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Retinal Drugs and Biologics Market Report 2018

1 RETINAL DRUGS AND BIOLOGICS OVERVIEW

1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Classification of Retinal Drugs and Biologics by Product Category
  1.2.1 United States Retinal Drugs and Biologics Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Retinal Drugs and Biologics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Surgery
  1.2.4 Medicines
  1.2.5 Retinal Laser
  1.2.6 Others
1.3 United States Retinal Drugs and Biologics Market by Application/End Users
  1.3.1 United States Retinal Drugs and Biologics Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Specialty Ophthalmology Clinics
  1.3.5 Others
1.4 United States Retinal Drugs and Biologics Market by Region
  1.4.1 United States Retinal Drugs and Biologics Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.3 Southwest Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.5 New England Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.6 The South Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.7 The Midwest Retinal Drugs and Biologics Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Retinal Drugs and Biologics (2013-2025)
  1.5.1 United States Retinal Drugs and Biologics Sales and Growth Rate (2013-2025)
  1.5.2 United States Retinal Drugs and Biologics Revenue and Growth Rate (2013-2025)

2 UNITED STATES RETINAL DRUGS AND BIOLOGICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Retinal Drugs and Biologics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Retinal Drugs and Biologics Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Retinal Drugs and Biologics Average Price by Players/Suppliers (2013-2018)
2.4 United States Retinal Drugs and Biologics Market Competitive Situation and Trends
  2.4.1 United States Retinal Drugs and Biologics Market Concentration Rate
  2.4.2 United States Retinal Drugs and Biologics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Retinal Drugs and Biologics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RETINAL DRUGS AND BIOLOGICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Retinal Drugs and Biologics Sales and Market Share by Region (2013-2018)
3.2 United States Retinal Drugs and Biologics Revenue and Market Share by Region (2013-2018)
3.3 United States Retinal Drugs and Biologics Price by Region (2013-2018)

4 UNITED STATES RETINAL DRUGS AND BIOLOGICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Retinal Drugs and Biologics Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Retinal Drugs and Biologics Revenue and Market Share by Type (2013-2018)
4.3 United States Retinal Drugs and Biologics Price by Type (2013-2018)
4.4 United States Retinal Drugs and Biologics Sales Growth Rate by Type (2013-2018)

5 UNITED STATES RETINAL DRUGS AND BIOLOGICS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Retinal Drugs and Biologics Sales and Market Share by Application (2013-2018)
5.2 United States Retinal Drugs and Biologics Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES RETINAL DRUGS AND BIOLOGICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alimera Sciences
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Janssen Biotech
  6.2.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 F. Hoffmann-La Roche Ltd
  6.3.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Genzyme Corporation
  6.4.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Genzyme Corporation Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Ocular Therapeutix
  6.5.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ocular Therapeutix Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 UCBCares
  6.6.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 UCBCares Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Allergan
  6.7.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Allergan Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 AbbVie Inc
  6.8.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AbbVie Inc Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Swedish Orphan Biovitrum
  6.9.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb Company
  6.10.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Genentech USA
6.12 Bausch & Lomb Incorporated

7 RETINAL DRUGS AND BIOLOGICS MANUFACTURING COST ANALYSIS

7.1 Retinal Drugs and Biologics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Retinal Drugs and Biologics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Retinal Drugs and Biologics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RETINAL DRUGS AND BIOLOGICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Retinal Drugs and Biologics Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Retinal Drugs and Biologics Sales Volume Forecast by Type (2018-2025)
11.3 United States Retinal Drugs and Biologics Sales Volume Forecast by Application (2018-2025)
11.4 United States Retinal Drugs and Biologics Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Retinal Drugs and Biologics
Figure United States Retinal Drugs and Biologics Market Size (K Units) by Type (2013-2025)
Figure United States Retinal Drugs and Biologics Sales Volume Market Share by Type (Product Category) in 2017
Figure Surgery Product Picture
Figure Medicines Product Picture
Figure Retinal Laser Product Picture
Figure Others Product Picture
Figure United States Retinal Drugs and Biologics Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Retinal Drugs and Biologics by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Specialty Ophthalmology Clinics Examples
Table Key Downstream Customer in Specialty Ophthalmology Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Retinal Drugs and Biologics Market Size (Million USD) by Region (2013-2025)
Figure The West Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2013-2025)
Figure United States Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Retinal Drugs and Biologics Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Retinal Drugs and Biologics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Retinal Drugs and Biologics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Retinal Drugs and Biologics Sales Share by Players/Suppliers
Figure 2017 United States Retinal Drugs and Biologics Sales Share by Players/Suppliers
Figure United States Retinal Drugs and Biologics Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Retinal Drugs and Biologics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Retinal Drugs and Biologics Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Retinal Drugs and Biologics Revenue Share by Players/Suppliers
Figure 2017 United States Retinal Drugs and Biologics Revenue Share by Players/Suppliers
Table United States Market Retinal Drugs and Biologics Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Retinal Drugs and Biologics Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Retinal Drugs and Biologics Market Share of Top 3 Players/Suppliers
Figure United States Retinal Drugs and Biologics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Retinal Drugs and Biologics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Retinal Drugs and Biologics Product Category
Table United States Retinal Drugs and Biologics Sales (K Units) by Region (2013-2018)
Table United States Retinal Drugs and Biologics Sales Share by Region (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Share by Region (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Market Share by Region in 2017
Table United States Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Retinal Drugs and Biologics Revenue Share by Region (2013-2018)
Figure United States Retinal Drugs and Biologics Revenue Market Share by Region (2013-2018)
Figure United States Retinal Drugs and Biologics Revenue Market Share by Region in 2017
Table United States Retinal Drugs and Biologics Price (USD/Unit) by Region (2013-2018)
Table United States Retinal Drugs and Biologics Sales (K Units) by Type (2013-2018)
Table United States Retinal Drugs and Biologics Sales Share by Type (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Share by Type (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Market Share by Type in 2017
Table United States Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Retinal Drugs and Biologics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type (2013-2018)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type in 2017
Table United States Retinal Drugs and Biologics Price (USD/Unit) by Types (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Growth Rate by Type (2013-2018)
Table United States Retinal Drugs and Biologics Sales (K Units) by Application (2013-2018)
Table United States Retinal Drugs and Biologics Sales Market Share by Application (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Market Share by Application (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Market Share by Application in 2017
Table United States Retinal Drugs and Biologics Sales Growth Rate by Application (2013-2018)
Figure United States Retinal Drugs and Biologics Sales Growth Rate by Application (2013-2018)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Genzyme Corporation Basic Information List
Table Genzyme Corporation Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Genzyme Corporation Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Ocular Therapeutix Basic Information List
Table Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Ocular Therapeutix Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table UCBCares Basic Information List
Table UCBCares Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure UCBCares Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure UCBCares Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure UCBCares Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Allergan Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Allergan Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table AbbVie Inc Basic Information List
Table AbbVie Inc Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure AbbVie Inc Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Swedish Orphan Biovitrum Basic Information List
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Revenue Market Share in United States (2013-2018)
Table Genentech USA Basic Information List
Table Bausch & Lomb Incorporated Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure Retinal Drugs and Biologics Industrial Chain Analysis
Table Raw Materials Sources of Retinal Drugs and Biologics Major Players/Suppliers in 2017
Table Major Buyers of Retinal Drugs and Biologics
Table Distributors/Traders List
Figure United States Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Retinal Drugs and Biologics Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Type in 2025
Table United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Application in 2025
Table United States Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Retinal Drugs and Biologics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Retinal Drugs and Biologics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Retinal Drugs and Biologics Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories